FREE Case Review (866) 588-0600

Actos Bladder Cancer Class Action Lawsuit Filed in Quebec

August 2, 2012 – Last month, a class action lawsuit was filed in Quebec, Canada on behalf of individuals who were diagnosed with bladder cancer after taking Takeda’s blockbuster diabetes drug Actos (generic: pioglitazone). The claim alleges that Takeda and Eli Lilly knew – or should have known – about the risks associated with their best-selling medication, but that they failed to adequately warn the public and medical communities about this risk. This is at least the second class action filed over Actos bladder cancer in Canada, after a similar claim was filed in Ontario last December.

Actos Bladder Cancer Lawsuit Update April 8, 2014: In the first U.S. trial of its kind, Takeda Pharmaceuticals and Eli Lilly were ordered to pay a total of $9 billion in punitive damages after a jury agreed that the companies failed to warn the public and medical communities about the bladder cancer risk associated with their controversial type 2 diabetes drug Actos (pioglitazone). The lawsuit claimed that Takeda and Lilly downplayed or ignored concerns about Actos’ link to bladder cancer, and mislead health authorities in order to protect profits. Click here to learn more.

Free Actos Lawsuit Evaluation: If you or a loved one was diagnosed with bladder cancer after taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Actos and we can help.

What’s the problem?

The new Actos class action lawsuit was filed in the Superior Court of Montreal on behalf of lead plaintiff Jimmy Whyte, who was diagnosed with bladder cancer earlier this year after having taken Actos to treat his diabetes since November 2008. Allegations raised in the complaint mirror numerous other similar lawsuits filed in courthouses around the country on behalf of individuals who allegedly developed bladder cancer after taking Actos, which suggest that Takeda and Eli Lilly were negligent in failing to properly research the drug, and for not warning the public and medical communities about the risks associated with it.

Over the past several years, Actos has been widely prescribed around the country, resulting in an estimated $4.3 billion in sales in 2011 alone, making it one of the 10 best-selling drugs in the United States. However, in the past year and a half, concerns have emerged about the risk of bladder cancer from Actos, after interim data from a decade-long study indicated that long-term use of the drug was linked to an increased risk for high-grade tumors.

In June 2011, the U.S. Food & Drug Administration (FDA) issued a press release stating that new information would be added to Actos warning labels indicating that long-term use of the drug (one year or longer) may increase the risk of developing bladder cancer. So far this year, a number of medical studies have been released confirming the risk of bladder cancer from Actos. New research published in the Canadian Medical Association Journal found that Actos users face a 22% increased risk of bladder cancer after using Actos for a year or longer.

All federal Actos bladder cancer lawsuits have been consolidated into a multidistrict litigation (MDL) before Judge Rebecca Doherty in the Western District of Louisiana. To date, nearly 800 complaints have been included in the MDL, which were filed on behalf of individuals who allegedly developed bladder cancer after taking Actos. MDLs are implemented to reduce duplicate discovery, avoid conflicting rulings from different judges, and to serve the convenience of all parties involved in the litigation. The first Actos trial date in the MDL is not scheduled to begin until November 2014, with a second trial to start in January 2015.

Do I Have an Actos Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Actos lawsuits. We are handling individual litigation nationwide and currently accepting new bladder cancer cases in all 50 states.

Free Actos Lawsuit Evaluation: If you or a loved one was diagnosed with bladder cancer after taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing an Actos bladder cancer suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition